The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).
 
Margaret A. Tempero
Research Funding - Celgene
 
Dana Backlund Cardin
Consulting or Advisory Role - Merrimack
Research Funding - Celgene; Genentech; Incyte; Synta
 
David Goldstein
Stock and Other Ownership Interests - Sirtex Medical
Research Funding - Amgen (Inst); Celgene (Inst); pfizer (Inst)
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Gilead Sciences; Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Merrimack; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics
Research Funding - Celgene (Inst); Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst); Polaris (Inst); Sanofi (Inst)
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Hanno Riess
Consulting or Advisory Role - AstraZeneca; Celgene; Merck
 
Teresa Macarulla
No Relationships to Disclose
 
Lotus Yung
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Mingyu Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Brian D. Lu
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Andrew Biankin
Stock and Other Ownership Interests - Cure Forward
Consulting or Advisory Role - Celgene